Physician profile
Long D Vu
NPI 1194723973
$6,082.50
in general payments reported to CMS, 2019-2025
18 companies · $3,745 in 2025
The $3,745 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $786 · 2021: $357 · 2022: $126 · 2023: $267 · 2024: $459 · 2025: $3,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,130 · Travel and Lodging: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.02 |
| Travel and Lodging | $1,340.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,397.19 | 2022-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,157.05 | 2019-2024 | Senza |
| Mml US, INC. | $707.35 | 2025 | Reactiv8 |
| Boston Scientific Corporation | $495.41 | 2019-2025 | Intracept |
| Stryker Corporation | $406.12 | 2020-2025 | Mild Device Kit, Optablate, Spinejack |
| Spr Therapeutics, INC | $398.91 | 2021-2024 | Sprint Pns System |
| Medtronic, INC. | $342.70 | 2025 | Inceptiv |
| Vertos Medical, INC. | $331.61 | 2020-2021 | |
| Saluda Medical Americas, INC. | $241.80 | 2025 | Evoke |
| Globus Medical, INC. | $179.98 | 2025 | Senza |
| Nalu Medical, INC. | $149.03 | 2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $92.93 | 2024-2025 | Belbuca |
| Abbvie INC. | $67.83 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.16 | 2024 | Relistor |
| Surgalign Spine Technologies, INC. | $28.16 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.46 | 2025 | |
| Baudax Bio INC. | $15.57 | 2020 | |
| Fidia Pharma USA INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Long Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.